Navigation Links
Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
Date:10/19/2010

ssed or implied in this press release due to a number of risks and uncertainties, including the risk that BYDUREON may not be approved by the FDA as soon as anticipated or at all; the companies' response to the complete response letter may not be submitted in a timely manner and/or the information provided in such response may not satisfy the FDA; the FDA may request additional information prior to approval; BYETTA and/or the approval of BYDUREON and the revenues generated from these products may be affected by competition; unexpected new data; safety and technical issues; clinical trials not being completed in a timely manner, not confirming previous results, not being predictive of real world use or not achieving the intended clinical endpoints; label expansion requests or NDA filings not receiving regulatory approval; the commercial launch of BYDUREON being delayed; or manufacturing and supply issues. The potential for BYETTA and/or BYDUREON may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical products including those inherent in the collaboration with and dependence upon Amylin, Lilly and/or Alkermes. These and additional risks and uncertainties are described more fully in Amylin's, Lilly's and Alkermes' most recent SEC filings including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Amylin, Lilly and Alkermes undertake no duty to update these forward-looking statements.

BYDUREON™ and BYETTA® are trademarks of Amylin Pharmaceuticals, Inc., and Medisorb® is a registered trademark of Alkermes, Inc. 

P-LLY

(i)The International Diabetes Federation Diabetes Atlas. Available at:

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
(Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
(Date:10/17/2014)...  Talyst, a market leader in pharmacy automation will ... Nashville, TN. The company will ... for onsite, remote medication dispensing. Talyst,s ... and securely dispense medication onsite, on demand. Remote dispensing ... that the correct medication gets to the correct patient ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4Talyst Exhibits at LeadingAge Annual Meeting 2
... 13, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... third quarter of 2010 on Wednesday, October 20, 2010 at ... and chief executive officer, will lead the call. On the ... third quarter of 2010.   The call will ...
... Following recent FDA approvals for prostate cancer treatment ... the lives of men with advanced prostate cancer ... from Johnson & Johnson. The drug, which could reach the ... with the potential to change clinical practice by providing ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Third Quarter Results 2Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2
(Date:10/20/2014)... MA (PRWEB) October 20, 2014 ... sponsoring a booth at the American Foundation for Suicide ... 25th. The AFSP is a not-for-profit organization that hosts ... Net proceeds from these events are used to help ... but education and personal relationships as well. , ...
(Date:10/20/2014)... October 20, 2014 hc1.com today ... secure cloud solution that enables healthcare organizations of ... ultimate healthcare-specific customer relationship management (“CRM”) solution. , ... unique needs of the healthcare industry, the hc1 ... providers and patients by combining healthcare CRM, HIPAA-compliant ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Principle Business ... takes pride in manufacturing top-of-the-line absorbent products. The ... of its most popular brand, Tranquility® Premium Protection absorbent ... a new website, gave its packaging a new look, ... the brand message to the public. , The new ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... highest risk, study finds , , TUESDAY, May 26 (HealthDay ... effects of alcohol, the greater your chance of becoming an alcoholic, ... sensitivity to imbibing intoxicants, called a low level of response (LR) ... get that buzz or other desired effect. The condition appears to ...
... Boston University School of Medicine (BUSM) and Boston University ... method fully resolves confounding by indication in observational studies, ... by unmeasured confounding, it is not straightforward to determine ... in obtaining a valid and precise estimate of effect. ...
... of East Asian and South Asian descent are between two ... at birth when compared to their Canadian counterparts, according to ... Ray. Dr. Ray and a team of researchers, who developed ... suggest the need to consider differences across ethnic groups to ...
... by researchers UT Southwestern Medical Center are accelerating efforts ... the world,s population. , The new findings, available online ... of the National Academy of Sciences, demonstrate that ... Caenorhabditis elegans, a common research worm, also provides the ...
... Washington, D.C. Tops List of America,s Fittest Cities SEATTLE, ... the fittest of America,s 50 most populous metropolitan areas ... American Fitness Index(TM) (AFI). ACSM unveiled the 2009 rankings ... Fitness Status of the 50 Largest Metropolitan Areas," during ...
... May 26 maxIT Healthcare LLC (maxIT), a ... the highest results in the staff augmentation category ... of the healthcare industry,s leading associations. According to ... published in February of 2009 by KLAS entitled ...
Cached Medicine News:Health News:Sensitivity to Alcohol May Predict Alcoholism 2Health News:BUSM researchers find no adjustment method fully resolves confounding by indication 2Health News:Newborns of South Asian and East Asian descent misclassified as underweight at birth: Study 2Health News:Researchers gain ground in efforts to fight parasite infection 2Health News:ACSM American Fitness Index(TM) Ranks 50 Largest Metro Areas on Health and Community Fitness 2Health News:ACSM American Fitness Index(TM) Ranks 50 Largest Metro Areas on Health and Community Fitness 3Health News:ACSM American Fitness Index(TM) Ranks 50 Largest Metro Areas on Health and Community Fitness 4Health News:ACSM American Fitness Index(TM) Ranks 50 Largest Metro Areas on Health and Community Fitness 5Health News:ACSM American Fitness Index(TM) Ranks 50 Largest Metro Areas on Health and Community Fitness 6Health News:ACSM American Fitness Index(TM) Ranks 50 Largest Metro Areas on Health and Community Fitness 7Health News:Is There a Meaningful Difference Between Healthcare IT Consulting Firms for Staff Augmentation? 2Health News:Is There a Meaningful Difference Between Healthcare IT Consulting Firms for Staff Augmentation? 3
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large devices for vascular intervention....
Used to introduce balloon, closed and non-tapered end catheters and other devices for intervention....
Medicine Products: